Andreas Gruentzig
Andreas Roland Gruentzig (June 25, 1939 – October 27, 1985) was a German cardiologist who is credited with developing the angioplasty procedure, a minimally invasive technique to treat coronary artery disease.
Early Life and Education[edit | edit source]
Gruentzig was born in Dresden, Germany. He studied medicine at the University of Heidelberg and later at the University of Zurich, where he completed his medical degree. His early work focused on the development of techniques to improve the treatment of cardiovascular disease.
Career and Innovations[edit | edit source]
In the 1970s, Gruentzig developed the technique of percutaneous transluminal coronary angioplasty (PTCA), which involves the use of a balloon catheter to dilate narrowed or blocked coronary arteries. This procedure was first performed on a human patient in 1977 and marked a significant advancement in the field of interventional cardiology.
Gruentzig's work revolutionized the treatment of heart disease, providing an alternative to coronary artery bypass grafting (CABG) for many patients. His innovations laid the groundwork for the development of modern stent technology and other percutaneous interventions.
Legacy[edit | edit source]
Andreas Gruentzig's contributions to medicine have had a lasting impact on the treatment of cardiovascular diseases. His pioneering work in angioplasty has saved countless lives and continues to influence the field of cardiology today.
Death[edit | edit source]
Gruentzig died in a plane crash in Forsyth, Georgia, United States, on October 27, 1985. Despite his untimely death, his legacy lives on through the continued use and development of angioplasty techniques.
See Also[edit | edit source]
References[edit | edit source]
Topol, EJ,
Andreas Gruentzig and the dawn of intervention, Journal of the American College of Cardiology, 2003, Vol. 42(Issue: 8), pp. 1610–1618, DOI: 10.1016/S0735-1097(03)00915-3,
R,
The History of Angioplasty, Springer, 2006, ISBN 978-1-4020-4561-2,
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD